Who invested in Trius Therapeutics?
Trius Therapeutics's investors include InterWest Partners, Versant Ventures, Sofinnova Investments and Prism VentureWorks.
United States · Venture startup
3 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$69Mraised across 3 rounds since 2007, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $30M sold, first sale May 2011
No investor was named in the report.
From a historical funding recordSEC filing: $19M sold, first sale Nov 2009
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Trius Therapeutics's investors include InterWest Partners, Versant Ventures, Sofinnova Investments and Prism VentureWorks.
Trius Therapeutics has raised $69M across 3 rounds since 2007.
Trius Therapeutics's most recent round was a Venture of $30M in Jun 2011.
Its most recent round, $30M in Jun 2011, is also its largest on record.
Trius Therapeutics's first round on record, in Feb 2007, was backed by InterWest Partners, Versant Ventures and Sofinnova Investments and 1 others.
Trius Therapeutics's latest named round is a Venture, in Jun 2011.
Trius Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.